Find out more about Grace Kong's experience
Grace Kong's highlights
FEATURED Conference Proceedings
Circulating tumour cells (CTCs) and PSMA PET correlates in the phase I PRINCE trial of 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC).
Read moreGrace Kong's selected work
Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrat..
Journal article
Efficacy and Safety of Lu-177-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
Journal article
Pivotal phase III COMPOSE trial will compare Lu-177-edotreotide with best standard of care..
Conference Proceedings
Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Austr..
Journal article
Optimal PLAnning of treatment and research of neuroendocrine tumours (NETs) in Australia: ..
Conference Proceedings
PRINCE: Interim analysis of the phase Ib study of Lu-177-PSMA-617 in combination with pemb..
Conference Proceedings
Grace Kong's selected work
Scholarly Works
Displaying the 10 most recent scholarly works from 41 for Grace Kong.
Keyword Analysis
Credentials
Positions
Honorary
The Sir Peter Maccallum Department of Oncology